Davenport & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-92,200
Closed -$249K 678
2016
Q3
$249K Hold
92,200
﹤0.01% 521
2016
Q2
$218K Buy
92,200
+500
+0.5% +$1.38K ﹤0.01% 533
2016
Q1
$296K Sell
91,700
-1,500
-2% -$5.54K ﹤0.01% 459
2015
Q4
$446K Sell
93,200
-91,400
-50% -$518K 0.01% 379
2015
Q3
$1.03M Buy
184,600
+25,241
+16% +$186K 0.02% 277
2015
Q2
$1.27M Buy
159,359
+51,400
+48% +$442K 0.02% 258
2015
Q1
$1.13M Buy
+107,959
New +$1.48M 0.02% 279

Other funds holding BDSI

Davenport & Co's BDSI Position: Q4 2016 in Review

Davenport & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2016, closing a stake of 92,200 shares — an estimated $249K sold.

Davenport & Co first reported a position in BDSI in Q1 2015 and held it in 7 quarters. The position peaked at $1.27M in Q2 2015. 77 funds tracked by Wall St. Rank hold BDSI as of Q4 2016.

  • Davenport & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2016 after selling out during the quarter.
  • Davenport & Co sold 92,200 BioDelivery Sciences International, Inc. shares in Q4 2016, an estimated $249K.
  • Davenport & Co first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 7 quarters.
  • Davenport & Co's BioDelivery Sciences International, Inc. position peaked at $1.27M in Q2 2015.
  • 77 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2016.

Based on Davenport & Co's 13F filing for Q4 2016, filed 5 Jan 2017.